PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjThe BMJ
 
BMJ. 1990 August 18; 301(6748): 359–362.
PMCID: PMC1679938

Short course chemotherapy for tuberculous lymphadenitis in children.

Abstract

OBJECTIVE--To assess the efficacy of a short course chemotherapy regimen for treating tuberculosis of the lymph nodes in children. DESIGN--Open, collaborative, outpatient clinical trial. SETTING--Outpatient department of the Tuberculosis Research Centre, paediatric surgery departments of the Institute of Child Health and Hospital for Children and the Government Stanley Hospital, Madras, South India. PATIENTS--Children aged 1-12 years with extensive, multiple site, superficial tuberculous lymphadenitis confirmed by biopsy (histopathology or culture). INTERVENTIONS--Patients were treated with a fully supervised intermittent chemotherapy regimen consisting of streptomycin, rifampicin, isoniazid, and pyrazinamide three times a week for two months followed by streptomycin and isoniazid twice a week for four months on an outpatient basis. Surgery was limited to biopsy of nodes for diagnosis and assessment. MAIN OUTCOME MEASURES--Response to chemotherapy was assessed by regression of lymph nodes and healing of sinuses and abscesses during treatment and follow up. Compliance with treatment and frequency of adverse reactions were also estimated. RESULTS--197 Patients were admitted to the study and 168 into the analysis. The regimen was well tolerated and compliance was good with 101 (60%) patients receiving the prescribed chemotherapy within 15 days of the stipulated period of six months. Those whose chemotherapy extended beyond that period received the same total number of doses. Clinical response was favourable in most patients at the end of treatment. Sinuses and abscesses healed rapidly. Residual lymphadenopathy (exceeding 10 mm diameter) was present in 50 (30%) patients at the end of treatment; these nodes were biopsied. Fresh nodes, increase in size of nodes, and sinuses and abscesses occurred both during treatment and follow up. After 36 months of follow up after treatment only 5 (3%) patients required retreatment for tuberculosis. CONCLUSION--Tuberculous lymphadenitis in children can be successfully treated with a short course chemotherapy regimen of six months.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (899K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Fox W. Whither short-course chemotherapy? Br J Dis Chest. 1981 Oct;75(4):331–357. [PubMed]
  • McCarthy OR, Rudd RM. Six months' chemotherapy for lymph node tuberculosis. Respir Med. 1989 Sep;83(5):425–427. [PubMed]
  • GILLAM PM, KNOWLES JP. The treatment of tuberculous lymphadenitis. Tubercle. 1963 Mar;44:112–118. [PubMed]
  • Campbell IA, Dyson AJ. Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle. 1977 Dec;58(4):171–179. [PubMed]
  • Campbell IA, Dyson AJ. Lymph node tuberculosis: a comparison of treatments 18 months after completion of chemotherapy. Tubercle. 1979 Jun;60(2):95–98. [PubMed]
  • Mitchison DA, Allen BW, Manickavasagar D. Selective Kirchner medium in the culture of specimens other than sputum for mycobacteria. J Clin Pathol. 1983 Dec;36(12):1357–1361. [PMC free article] [PubMed]
  • Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Smelev NA. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ. 1969;41(1):21–43. [PubMed]
  • Pamra SP, Mathur GP. A cooperative study of tuberculous cervical lymphadenitis. Indian J Med Res. 1974 Nov;62(11):1631–1646. [PubMed]

Articles from The BMJ are provided here courtesy of BMJ Publishing Group